1,000+ M&A transactions for an aggregate value of $375+ billion since 2017
The American Lawyer Names Cooley Tech Practice of the Year
Learn More
VelosBio Agrees to Sell to Merck for $2.75 Billion
Learn More
Twilio Agrees to Acquire Segment for $3.2 Billion
Learn More
Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company
Learn More
Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion
Learn More
Sunrun to Acquire Vivint Solar for Enterprise Value of $3.2 Billion
Learn More
MIRROR Agrees to Sell to lululemon for $500 Million
Learn More
ArcherDX Agrees to Combine With Invitae in $2.7 Billion Deal
Learn More
Why Cooley
- 180+ member team in 16 major business and technology centers in the US, Europe and Asia
- Broad industry platform with clients across many industries and sophisticated capabilities in all practice areas
- Excel in deals in the tech, life sciences, medical device and healthcare, consumer, education, defense and media industries
- Given our market position in the medtech and life sciences sectors, we have handled a large number of life sciences M&A transactions, both public and private, and understand unique structuring issues for life sciences companies, including milestone structures, contingent value rights and option structures
- Primary corporate counsel to 190+ public companies, giving us an unmatched perspective on market deal points and ability to facilitate introductions between buyers and sellers
- Represent all categories of participants in transactions, including buyers, sellers, major stockholders, venture capitalists, lenders, financial advisors, management/founders, special board committees, individual investors, private equity funds, hedge funds and others
- Adept at handling all manner of transactions, including domestic and cross-border mergers and acquisitions, strategic deals including joint ventures, acquisitions of IP assets, patent cross-licenses, complex divestitures and spin-offs, takeover defense and shareholder activism counseling, and multibillion-dollar public company mergers
- Robust SPAC experience and thought leaders in the area with a repository of market insight and guidance for businesses interested in the IPO alternative @ SPACtivity
- Market-leading IP, privacy, technology licensing, life sciences collaborations and licensing, regulatory, government contracts, credit finance, private equity, antitrust, employment, compensation and tax practices to support transactions
Recognition
- The Legal 500: Tier 2 M&A: Middle-Market (2020)
- Best Lawyers (National): Tier 1 M&A (2020)
- The Recorder: Tech Deal Firm of the Year (2019)
- PitchBook: #1 in VC-Backed Exits by count (M&A + IPO) (2019)
- Mergermarket: Top 10 in US M&A by count (2020)
- Mergermarket: Top 5 for M&A Exits (2020)
- The Deal: Top 20 M&A Law Firms Power Rankings by count (2019)
M&A Blog
Newsworthy developments in the global mergers and acquisitions space
View blog
ViewHide related contacts
+-
Listing Returned 0 Results.
ViewHide related news
+-
Listing Returned 0 Results.
ViewHide related events
+-
Listing Returned 0 Results.